Superinvestor Tracker
← 전체 투자자

ARRIVENT BIOPHARMA INC

AVBP

보유 투자자

5

합산 평가액

$36M

합산 보유 주식 수

1,565,399

현재가

$31.36

52주 최고가

$33.62

52주 최고가 대비

−6.7%

투자자 매매

$16.81$20.85$24.89$28.93Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26▲1▲2▲1 ▼1▲2 ▼1▲4 ▼1▲1 ▼2▲2 ▼3▲4 ▼1
매수매도추정 단가분기를 클릭해 거래한 투자자 보기

보유 투자자

투자자평가액포트폴리오 비중평균 매입단가수익률최근 매매기준
Steve Cohen - Point72$17M0.02%~$22.22+41.2%매수 Q1 2026Q1 2026
Israel Englander - Millennium Management$9.8M0.00%~$20.74+51.2%매수 Q1 2026Q1 2026
Ken Griffin - Citadel Advisors$8.1M0.00%~$20.12+55.9%매도 Q1 2026Q1 2026
Paul Tudor Jones - Tudor Investment$509K0.00%~$23.07+35.9%매수 Q1 2026Q1 2026
Cliff Asness - AQR Capital$367K0.00%~$22.13+41.7%매수 Q1 2026Q1 2026

최근 매매

분기투자자구분추정 금액추정 단가
Q1 2026Steve Cohen - Point72매수+$12M~$23.07
Q1 2026Israel Englander - Millennium Management매수+$3.3M~$23.07
Q1 2026Ken Griffin - Citadel Advisors매도−$2.4M~$23.07
Q1 2026Paul Tudor Jones - Tudor Investment신규 매수+$509K~$23.07
Q1 2026Cliff Asness - AQR Capital매수+$102K~$23.07
Q4 2025Ken Griffin - Citadel Advisors신규 매수+$9.2M~$20.12
Q4 2025Leon Cooperman - Omega Family Office전량 매도−$7.8M~$18.45
Q4 2025Steve Cohen - Point72신규 매수+$4.4M~$20.12
Q4 2025Israel Englander - Millennium Management매도−$83K~$20.12
Q4 2025Cliff Asness - AQR Capital매도−$7.0K~$20.12
Q3 2025Israel Englander - Millennium Management매수+$2.0M~$18.45
Q3 2025Ken Griffin - Citadel Advisors전량 매도−$732K~$21.77
Q3 2025Cliff Asness - AQR Capital매도−$46K~$18.45
Q2 2025Leon Cooperman - Omega Family Office신규 매수+$9.2M~$21.77
Q2 2025Ken Griffin - Citadel Advisors신규 매수+$732K~$21.77
Q2 2025Israel Englander - Millennium Management매수+$394K~$21.77
Q2 2025Paul Tudor Jones - Tudor Investment전량 매도−$282K~$18.49
Q2 2025Cliff Asness - AQR Capital신규 매수+$312K~$21.77
Q1 2025Israel Englander - Millennium Management매수+$2.0M~$18.49
Q1 2025Paul Tudor Jones - Tudor Investment신규 매수+$282K~$18.49
Q1 2025Cliff Asness - AQR Capital전량 매도−$236K~$26.64
Q4 2024Israel Englander - Millennium Management매도−$4.4M~$26.64
Q4 2024Cliff Asness - AQR Capital매수+$5.6K~$26.64
Q3 2024Israel Englander - Millennium Management매수+$4.8M~$23.50
Q3 2024Cliff Asness - AQR Capital신규 매수+$203K~$23.50

보유 현황 추이

분기보유 투자자총 보유 주식 수주식 수 증감총 평가액추정 단가
Q1 202651,565,399+61.6%$36M$23.07
Q4 20254968,589+34.7%$19M$20.12
Q3 20253719,205+11.4%$13M$18.45
Q2 20254645,438+272.3%$14M$21.77
Q1 20252173,351+182.3%$3.2M$18.49
Q4 2024261,413−72.7%$1.6M$26.64
Q3 20242225,287+1761.4%$5.3M$23.50
Q2 2024112,103—$224K$18.55